Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects
- PMID: 3472488
- PMCID: PMC174735
- DOI: 10.1128/AAC.31.3.375
Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects
Abstract
The influence of multiple doses of ofloxacin (ORF 18489) on the disposition of theophylline was studied in 15 male volunteers. Subjects were confined in the Clinical Research Unit for 13 days and given a xanthine-free diet. A single dose (3 mg/kg) of theophylline was given orally, and blood samples were collected at fixed time intervals for 36 h. The concentrations of theophylline were measured with TDX (Abbott Diagnostics, Irving, Tex.), and clearance was calculated. Theophylline clearance was used to individualize subsequent doses to achieve average steady-state theophylline concentrations in plasma of 10 mg/liter. Individualized theophylline doses were administered every 8 h until steady-state conditions were reached. Theophylline clearance was determined again at steady state and on days 7 and 8. On day 8, ofloxacin (400 mg every 12 h) was given concomitantly with theophylline. Theophylline clearance was measured again on day 12, after the last theophylline dose. Administration of ofloxacin for 1 day did not change theophylline clearance, but coadministration for 4 days significantly decreased theophylline clearance by 12.1% (P less than 0.05). The area under the concentration-time curve for theophylline increased 9.9% (P less than 0.05), and average steady-state concentrations in plasma increased 10.3% (P less than 0.05). Despite changes in clearance, adverse effects of theophylline did not increase during coadministration of ofloxacin. Although statistically significant, the interaction between ofloxacin and theophylline is unlikely to be of major clinical importance.
Similar articles
-
Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose.Ther Drug Monit. 1988;10(2):160-3. doi: 10.1097/00007691-198802000-00007. Ther Drug Monit. 1988. PMID: 3164150
-
Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration.Eur J Clin Pharmacol. 1987;32(4):431-2. doi: 10.1007/BF00543982. Eur J Clin Pharmacol. 1987. PMID: 3475207
-
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S72-5. doi: 10.1007/BF02075266. Pharm Weekbl Sci. 1987. PMID: 3481439
-
Interaction between the fluoroquinolones and the bronchodilator theophylline.J Antimicrob Chemother. 1988 Sep;22 Suppl C:109-14. doi: 10.1093/jac/22.supplement_c.109. J Antimicrob Chemother. 1988. PMID: 3053575 Review.
-
Inhibition of drug metabolism by quinolone antibiotics.Clin Pharmacokinet. 1988 Sep;15(3):194-204. doi: 10.2165/00003088-198815030-00004. Clin Pharmacokinet. 1988. PMID: 3052987 Review.
Cited by
-
Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.Antimicrob Agents Chemother. 1990 Jun;34(6):1249-53. doi: 10.1128/AAC.34.6.1249. Antimicrob Agents Chemother. 1990. PMID: 2118328 Free PMC article.
-
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008. Drugs. 1991. PMID: 1723377 Review.
-
Clinical pharmacokinetics of ciprofloxacin.Clin Pharmacokinet. 1990 Dec;19(6):434-61. doi: 10.2165/00003088-199019060-00003. Clin Pharmacokinet. 1990. PMID: 2292168 Review.
-
Pharmacokinetics of quinolones: newer aspects.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):267-74. doi: 10.1007/BF01967000. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864287 Review.
-
Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.Antimicrob Agents Chemother. 1995 Sep;39(9):2138-40. doi: 10.1128/AAC.39.9.2138. Antimicrob Agents Chemother. 1995. PMID: 8540732 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources